About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Precision Treatment With Angiotensin Converting Enzyme Inhibitor

NCT05535595·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Yonsei University

Age

20–79

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Men and women over 20 years of age and less than 79 years of age
Hypertension
No history of ACEI use

You may not be if

Acute coronary syndrome, cerebrovascular accident, symptomatic peripheral artery disease, or coronary revascularization in the past three months
Decompensated heart failure
Systolic blood pressure ≥180 mmHg or diastolic blood pressure ≥110 mmHg
Hemoglobin A1c \>9.0%
Thyroid dysfunction
Serum transaminase \>2 times the upper limit of normal levels
Serum creatinine \>2.0 mg/dL
Cancer
Pregnant or breast-feeding women, and women of childbearing potential
Patients who refused to participate

The record

StatusCompleted

PhasePhase 4

Taking part77

StartedNov 2019

UpdatedJan 11, 2023

Conditions

Where1

Yonsei University Health System, Severance Hospital
Seoul, South Korea

Clareo Health | Precision Treatment With Angiotensin Converting Enzyme Inhibitor